approval
saveGABAPENTIN — FDA approval
community read0 votes
Sponsor: ACTAVIS ELIZABETH. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalGABAPENTIN — FDA approvalApr 2, 2026 · 185d ago
- approvalGABAPENTIN — FDA approvalMar 6, 2026 · 212d ago
- approvalGABAPENTIN — FDA approvalJan 29, 2026 · 248d ago
- approvalGABAPENTIN — FDA approvalJan 29, 2026 · 248d ago
- approvalGABAPENTIN — FDA approvalDec 17, 2025 · 291d ago
- approvalGABAPENTIN — FDA approvalNov 24, 2025 · 314d ago
- approvalGABAPENTIN — FDA approvalSep 19, 2025 · 380d ago
- approvalGABAPENTIN — FDA approvalJul 21, 2025 · 440d ago
same company · ±60 days · 2
🐶 often sniffed alongside
top 8- tagApproval240 co-mentions · 120 sources
- drugGralise127 co-mentions · 127 sources
- drugNeurontin127 co-mentions · 127 sources
- tagSmall Molecule120 co-mentions · 120 sources
- companyActavis Elizabeth LLC18 co-mentions · 18 sources
- companyStrides Pharma Inc13 co-mentions · 13 sources
- tagRecall7 co-mentions · 7 sources
- companySun Pharmaceutical Industries Ltd6 co-mentions · 2 sources
comments(0)
5-min edit window · permanent after that